192 related articles for article (PubMed ID: 37810490)
1. Retracted: Bioinformatics Analysis of the Characteristics and Correlation of m6A Methylation in Breast Cancer Progression.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9874020. PubMed ID: 37810490
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics Analysis of the Characteristics and Correlation of m6A Methylation in Breast Cancer Progression.
Zhao P; Huang X; Wu A; Yang X; Fu Y; Quan Y; Zhang J; Li Z; Tang Q; Wang M
Contrast Media Mol Imaging; 2022; 2022():4416439. PubMed ID: 35655723
[TBL] [Abstract][Full Text] [Related]
3. Retracted: m6A RNA Methylation Regulators Contribute to Predict and as a Therapy Target of Pulmonary Fibrosis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9890723. PubMed ID: 38093871
[TBL] [Abstract][Full Text] [Related]
4. Retracted: MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9831697. PubMed ID: 38124948
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Identification of an m6A RNA Methylation Regulator Risk Score Model for Prediction of Clinical Prognosis in Astrocytoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9896149. PubMed ID: 38094352
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Identification and Verification of Key Tumor Genes Associated with Diagnosis and Prognosis of Breast Cancer Based on Bioinformatics Analysis.
Markers D
Dis Markers; 2023; 2023():9805152. PubMed ID: 37502594
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Sevoflurane Inhibits lncRNA HOTAIR-Modulated Stability of HK2 mRNA in a m6A-Dependent Manner to Dampen Aerobic Glycolysis and Proliferation in Lung Cancer.
International BR
Biomed Res Int; 2023; 2023():9805840. PubMed ID: 38075331
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Identification of Nine M6A-Related Long Noncoding RNAs as Prognostic Signatures Associated with Oxidative Stress in Oral Cancer Based on Data from The Cancer Genome Atlas.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9796081. PubMed ID: 38189018
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.
Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB
J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Bioinformatics Method Was Used to Analyze the Highly Expressed Gene FAM83A of Breast Cancer in Young Women.
And Biomechanics AB
Appl Bionics Biomech; 2023; 2023():9781396. PubMed ID: 38075133
[TBL] [Abstract][Full Text] [Related]
11. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation.
Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D
Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151
[TBL] [Abstract][Full Text] [Related]
12. Retracted: PCBP2 Reduced Oxidative Stress-Induced Apoptosis in Glioma through cGAS/STING Pathway by METTL3-Mediated m6A Modification.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9813487. PubMed ID: 37810561
[TBL] [Abstract][Full Text] [Related]
13. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q
J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Bioinformatics Analysis Identifies
Markers D
Dis Markers; 2023; 2023():9894804. PubMed ID: 37886108
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Inhibition of TLR4 Suppresses the Inflammatory Response in Inflammatory Bowel Disease (IBD) by Modulating the PDK1-Induced Metabolism Reprogramming via a m6A-Denpendent Manner.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9872016. PubMed ID: 37811274
[TBL] [Abstract][Full Text] [Related]
16. Retracted: Correlation of CCNA1 Promoter Methylation with Malignant Tumors: A Meta-Analysis Introduction.
International BR
Biomed Res Int; 2021; 2021():2608067. PubMed ID: 33681351
[TBL] [Abstract][Full Text] [Related]
17. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of the correlation between m6A RNA methylation regulators and the immune infiltration and prognosis of bladder cancer.
Wu J; Wang X; Xu H; Tian J; Ji H; Zhu J; Guo H; Chen Z
Ann Transl Med; 2022 Dec; 10(24):1386. PubMed ID: 36660722
[TBL] [Abstract][Full Text] [Related]
19. m6A RNA methylation regulators could contribute to the occurrence of chronic obstructive pulmonary disease.
Huang X; Lv D; Yang X; Li M; Zhang H
J Cell Mol Med; 2020 Nov; 24(21):12706-12715. PubMed ID: 32961012
[TBL] [Abstract][Full Text] [Related]
20. Retracted: Correlation between Breast Ultrasound Microcalcification and the Prognosis of Breast Cancer.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9837582. PubMed ID: 37946920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
